fundvisualizer.com

Rydex Dow 2x Strategy CRYCYX

Performance (before sales charge)

As of 03/31/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 12/31/2023
Stock
98.13%
Non-U.S. Stock
0.00%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
10.92%
Other
-9.05%

Due to rounding, percentages may not equal 100%.

Sectors

As of 12/31/2023

Basic materials

0.93%

Consumer cyclical

12.76%

Financial services

20.28%

Real estate

0.00%

Consumer defensive

6.17%

Health care

18.79%

Utilities

0.00%

Communication services

2.17%

Energy

2.53%

Industrials

14.86%

Technology

18.61%

Top 10 holdings

As of 12/31/2023

Other Assets & Liabilities
9.05%
UnitedHealth Group Inc
8.94%
United States Treasury Bills 5.27%
8.25%
The Goldman Sachs Group Inc
6.55%
Microsoft Corp
6.39%
The Home Depot Inc
5.88%
McDonald's Corp
5.04%
Caterpillar Inc
5.02%
Amgen Inc
4.89%
Salesforce Inc
4.47%
Fund assets

$53.16 Million

Share class

C

Morningstar category

Trading--Leveraged Equity

Expense ratio

2.61%

Investment objective

Growth

Documents